MRC Epidemiology Unit - Publications Database

Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: An observational analysis of the ADDITION-Europe trial.

Strelitz J, Sharp SJ, Khunti K, Vos RC, Rutten GEHM, Webb DR, Witte DR, Sandbaek A, Wareham NJ, Griffin SJ

Diabetes, obesity & metabolism. Jul 2020

(DOI : 10.1111/dom.14278)

Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.

Dalsgaard EM, Sandbaek A, Griffin SJ, Rutten GEHM, Khunti K, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, Witte DR

Diabetic medicine : a journal of the British Diabetic Association. Jun 2020

(DOI : 10.1111/dme.14342)

Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.

Griffin SJ, Rutten GEHM, Khunti K, Witte DR, Lauritzen T, Sharp SJ, Dalsgaard EM, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, Sandbæk A

The lancet. Diabetes & endocrinology. Nov 2018

(DOI : 10.1016/S2213-8587(19)30349-3)

Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes.

Webb DR, Zaccardi F, Davies MJ, Griffin SJ, Wareham NJ, Simmons RK, Rutten GE, Sandbaek A, Lauritzen T, Borch-Johnsen K, Khunti K

Diabetes/metabolism research and reviews. Aug 2016

(DOI : 10.1002/dmrr.2877)

Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.

Webb DR, Khunti K, Gray LJ, Srinivasan BT, Farooqi A, Wareham NJ, Griffin SC, Davies MJ

Diabetic medicine : a journal of the British Diabetic Association. Sep 2011

(DOI : 10.1111/j.1464-5491.2011.03441.x)

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.

Webb DR, Gray LJ, Khunti K, Srinivasan B, Taub N, Campbell S, Barnett J, Farooqi A, Echouffo-Tcheugui JB, Griffin SJ, Wareham NJ, Davies MJ

Diabetologia. Oct 2010

(DOI : 10.1007/s00125-011-2189-2)

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.

Webb DR, Khunti K, Srinivasan B, Gray LJ, Taub N, Campbell S, Barnett J, Henson J, Hiles S, Farooqi A, Griffin SJ, Wareham NJ, Davies MJ

Trials. Nov 2009

(DOI : 10.1186/1745-6215-11-16)